[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Covid-19 Impact on Epistaxis Market, Global Research Reports 2020-2021

June 2020 | 97 pages | ID: C47288A0017FEN
QYResearch

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report covers market size and forecasts of Epistaxis, including the following market information:
  • Global Epistaxis Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
  • Global Epistaxis Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
  • Global Epistaxis Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
  • Global Epistaxis Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players

Major competitors identified in this market include Smith & Nephew, Medline, Bristol-Myers Squibb Pharma Company, Ciron Drugs, King Pharmaceuticals, Inc, etc.

Based on the Region:
  • Asia-Pacific (China, Japan, South Korea, India and ASEAN)
  • North America (US and Canada)
  • Europe (Germany, France, UK and Italy)
  • Rest of World (Latin America, Middle East & Africa)
Based on the Type:
  • Vasoconstrictors
  • Anesthetics
  • Antibiotic Ointments
  • Cauterizing Agents
Based on the Application:
  • Pediatric
  • Adult
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
  1.4.1 Research Process
  1.4.2 Data Triangulation
  1.4.3 Research Approach
  1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
  1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.5.2 Covid-19 Impact: Commodity Prices Indices
  1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Epistaxis Industry
1.7 COVID-19 Impact: Epistaxis Market Trends

2 GLOBAL EPISTAXIS QUARTERLY MARKET SIZE ANALYSIS

2.1 Epistaxis Business Impact Assessment - COVID-19
  2.1.1 Global Epistaxis Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
  2.1.2 Global Epistaxis Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Epistaxis Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  2.3.1 Drivers
  2.3.2 Restraints
  2.3.3 Opportunities
  2.3.4 Challenges

3 QUARTERLY COMPETITIVE ASSESSMENT, 2020

3.1 Global Epistaxis Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Epistaxis Factory Price by Manufacturers
3.3 Location of Key Manufacturers Epistaxis Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Epistaxis Market
3.5 Key Manufacturers Epistaxis Product Offered
3.6 Mergers & Acquisitions, Expansion Plans

4 IMPACT OF COVID-19 ON EPISTAXIS SEGMENTS, BY TYPE

4.1 Introduction
  1.4.1 Vasoconstrictors
  1.4.2 Anesthetics
  1.4.3 Antibiotic Ointments
  1.4.4 Cauterizing Agents
4.2 By Type, Global Epistaxis Market Size, 2019-2021
  4.2.1 By Type, Global Epistaxis Market Size by Type, 2020-2021
  4.2.2 By Type, Global Epistaxis Price, 2020-2021

5 IMPACT OF COVID-19 ON EPISTAXIS SEGMENTS, BY APPLICATION

5.1 Overview
  5.5.1 Pediatric
  5.5.2 Adult
5.2 By Application, Global Epistaxis Market Size, 2019-2021
  5.2.1 By Application, Global Epistaxis Market Size by Application, 2019-2021
  5.2.2 By Application, Global Epistaxis Price, 2020-2021

6 GEOGRAPHIC ANALYSIS

6.1 Introduction
6.2 North America
  6.2.1 Macroeconomic Indicators of US
  6.2.2 US
  6.2.3 Canada
6.3 Europe
  6.3.1 Macroeconomic Indicators of Europe
  6.3.2 Germany
  6.3.3 France
  6.3.4 UK
  6.3.5 Italy
6.4 Asia-Pacific
  6.4.1 Macroeconomic Indicators of Asia-Pacific
  6.4.2 China
  6.4.3 Japan
  6.4.4 South Korea
  6.4.5 India
  6.4.6 ASEAN
6.5 Rest of World
  6.5.1 Latin America
  6.5.2 Middle East and Africa

7 COMPANY PROFILES

7.1 Smith & Nephew
  7.1.1 Smith & Nephew Business Overview
  7.1.2 Smith & Nephew Epistaxis Quarterly Production and Revenue, 2020
  7.1.3 Smith & Nephew Epistaxis Product Introduction
  7.1.4 Smith & Nephew Response to COVID-19 and Related Developments
7.2 Medline
  7.2.1 Medline Business Overview
  7.2.2 Medline Epistaxis Quarterly Production and Revenue, 2020
  7.2.3 Medline Epistaxis Product Introduction
  7.2.4 Medline Response to COVID-19 and Related Developments
7.3 Bristol-Myers Squibb Pharma Company
  7.3.1 Bristol-Myers Squibb Pharma Company Business Overview
  7.3.2 Bristol-Myers Squibb Pharma Company Epistaxis Quarterly Production and Revenue, 2020
  7.3.3 Bristol-Myers Squibb Pharma Company Epistaxis Product Introduction
  7.3.4 Bristol-Myers Squibb Pharma Company Response to COVID-19 and Related Developments
7.4 Ciron Drugs
  7.4.1 Ciron Drugs Business Overview
  7.4.2 Ciron Drugs Epistaxis Quarterly Production and Revenue, 2020
  7.4.3 Ciron Drugs Epistaxis Product Introduction
  7.4.4 Ciron Drugs Response to COVID-19 and Related Developments
7.5 King Pharmaceuticals, Inc
  7.5.1 King Pharmaceuticals, Inc Business Overview
  7.5.2 King Pharmaceuticals, Inc Epistaxis Quarterly Production and Revenue, 2020
  7.5.3 King Pharmaceuticals, Inc Epistaxis Product Introduction
  7.5.4 King Pharmaceuticals, Inc Response to COVID-19 and Related Developments

8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS

8.1 Epistaxis Supply Chain Analysis
  8.1.1 Epistaxis Supply Chain Analysis
  8.1.2 Covid-19 Impact on Epistaxis Supply Chain
8.2 Distribution Channels Analysis
  8.2.1 Epistaxis Distribution Channels
  8.2.2 Covid-19 Impact on Epistaxis Distribution Channels
  8.2.3 Epistaxis Distributors
8.3 Epistaxis Customers

9 KEY FINDINGS

10 APPENDIX

10.1 About Us
10.2 Disclaimer
LIST OF TABLES

Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Epistaxis Assessment
Table 9. COVID-19 Impact: Epistaxis Market Trends
Table 10. COVID-19 Impact Global Epistaxis Market Size
Table 11. Global Epistaxis Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Epistaxis Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Epistaxis Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Epistaxis Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Epistaxis Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Epistaxis Market Growth Drivers
Table 17. Global Epistaxis Market Restraints
Table 18. Global Epistaxis Market Opportunities
Table 19. Global Epistaxis Market Challenges
Table 20. Key Manufacturers Epistaxis Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Epistaxis Market Size, 2019 (K Units) & (US$ Million)
Table 22. Epistaxis Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Epistaxis Manufacturing Plants
Table 24. Key Manufacturers Epistaxis Market Served
Table 25. Date of Key Manufacturers Enter into Epistaxis Market
Table 26. Key Manufacturers Epistaxis Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Epistaxis Market Size by Type, 2020, (US$ Million)
Table 29. Global Epistaxis Market Size by Type, 2020 (K Units)
Table 30. Global Epistaxis Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Epistaxis Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Epistaxis Market Size by Application, 2020-2021 (K Units)
Table 33. Global Epistaxis Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Epistaxis Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Epistaxis Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Epistaxis Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Epistaxis Market Size, 2019-2021 (K Units)
Table 38. US Epistaxis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Epistaxis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Epistaxis Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Epistaxis Market Size, 2019-2021 (K Units)
Table 43. Germany Epistaxis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Epistaxis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Epistaxis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Epistaxis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Epistaxis Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Epistaxis Market Size, 2019-2021 (K Units)
Table 50. China Epistaxis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Epistaxis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Epistaxis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Epistaxis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Epistaxis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Epistaxis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Epistaxis Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Smith & Nephew Business Overview
Table 58. Smith & Nephew Epistaxis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Smith & Nephew Epistaxis Product
Table 60. Smith & Nephew Response to COVID-19 and Related Developments
Table 61. Medline Business Overview
Table 62. Medline Epistaxis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Medline Epistaxis Product
Table 64. Medline Response to COVID-19 and Related Developments
Table 65. Bristol-Myers Squibb Pharma Company Business Overview
Table 66. Bristol-Myers Squibb Pharma Company Epistaxis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bristol-Myers Squibb Pharma Company Epistaxis Product
Table 68. Bristol-Myers Squibb Pharma Company Response to COVID-19 and Related Developments
Table 69. Ciron Drugs Business Overview
Table 70. Ciron Drugs Epistaxis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Ciron Drugs Epistaxis Product
Table 72. Ciron Drugs Response to COVID-19 and Related Developments
Table 73. King Pharmaceuticals, Inc Business Overview
Table 74. King Pharmaceuticals, Inc Epistaxis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. King Pharmaceuticals, Inc Epistaxis Product
Table 76. King Pharmaceuticals, Inc Response to COVID-19 and Related Developments
Table 77. Epistaxis Distributors List
Table 78. Epistaxis Customers List
Table 79. Covid-19 Impact on Epistaxis Customers

LIST OF FIGURES

Figure 1. Epistaxis Product Picture
Figure 2. Epistaxis Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Epistaxis Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Epistaxis Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Epistaxis Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Epistaxis Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Epistaxis Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Epistaxis Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Epistaxis Market Size Market Share, 2019-2021


More Publications